VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 559 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2015. The put-call ratio across all filers is 1.96 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $89,069,000 | +24.2% | 3,832,561 | -14.9% | 0.02% | +33.3% |
| Q1 2018 | $71,732,000 | -39.4% | 4,505,748 | -21.0% | 0.02% | -35.7% |
| Q4 2017 | $118,455,000 | +16.3% | 5,700,450 | -19.8% | 0.03% | +12.0% |
| Q3 2017 | $101,832,000 | -25.2% | 7,106,190 | -9.7% | 0.02% | -30.6% |
| Q2 2017 | $136,078,000 | +70.4% | 7,865,843 | +8.6% | 0.04% | +63.6% |
| Q1 2017 | $79,863,000 | -25.4% | 7,240,534 | -1.8% | 0.02% | -26.7% |
| Q4 2016 | $107,013,000 | -42.8% | 7,370,023 | -3.3% | 0.03% | -47.4% |
| Q3 2016 | $187,198,000 | +13.1% | 7,625,195 | -7.2% | 0.06% | +5.6% |
| Q2 2016 | $165,556,000 | -36.1% | 8,220,288 | -16.5% | 0.05% | -36.5% |
| Q1 2016 | $258,895,000 | -74.4% | 9,843,870 | -1.2% | 0.08% | -73.3% |
| Q4 2015 | $1,012,378,000 | +67.5% | 9,959,447 | +193.9% | 0.32% | +55.9% |
| Q3 2015 | $604,460,000 | +4.8% | 3,388,611 | +30.5% | 0.20% | +14.6% |
| Q2 2015 | $576,911,000 | +11.8% | 2,596,944 | -0.0% | 0.18% | +7.2% |
| Q1 2015 | $516,042,000 | -32.5% | 2,598,134 | -51.4% | 0.17% | -31.4% |
| Q4 2014 | $764,415,000 | +21.3% | 5,341,457 | +11.2% | 0.24% | +21.0% |
| Q3 2014 | $629,955,000 | -23.7% | 4,801,484 | -26.6% | 0.20% | -22.8% |
| Q2 2014 | $825,204,000 | +87.3% | 6,543,009 | +95.8% | 0.26% | +79.9% |
| Q1 2014 | $440,579,000 | +61.9% | 3,342,020 | +44.2% | 0.14% | +60.0% |
| Q4 2013 | $272,057,000 | +19.5% | 2,317,354 | +6.2% | 0.09% | +7.1% |
| Q3 2013 | $227,671,000 | +24.6% | 2,182,221 | +2.8% | 0.08% | +20.0% |
| Q2 2013 | $182,755,000 | -14.2% | 2,123,081 | -40.4% | 0.07% | -20.5% |
| Q4 2012 | $212,914,000 | -2.4% | 3,562,227 | -9.8% | 0.09% | +1.1% |
| Q3 2012 | $218,161,000 | +49.1% | 3,947,194 | +20.8% | 0.09% | +33.8% |
| Q2 2012 | $146,310,000 | -18.1% | 3,266,577 | -1.8% | 0.06% | -22.6% |
| Q1 2012 | $178,648,000 | – | 3,327,401 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |